<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>Publicaciones</title>
<link href="http://hdl.handle.net/10952/2101" rel="alternate"/>
<subtitle/>
<id>http://hdl.handle.net/10952/2101</id>
<updated>2026-06-01T19:07:29Z</updated>
<dc:date>2026-06-01T19:07:29Z</dc:date>
<entry>
<title>Privacidad y derechos fundamentales en la Smart City: La utilización de la Inteligencia Artificial en los sistemas de videovigilancia</title>
<link href="http://hdl.handle.net/10952/11023" rel="alternate"/>
<author>
<name>Aranda Serna, Francisco José</name>
</author>
<id>http://hdl.handle.net/10952/11023</id>
<updated>2026-06-01T10:34:11Z</updated>
<published>2026-05-30T00:00:00Z</published>
<summary type="text">Privacidad y derechos fundamentales en la Smart City: La utilización de la Inteligencia Artificial en los sistemas de videovigilancia
Aranda Serna, Francisco José
Este artículo analiza las implicaciones sociales, éticas y  jurídicas del uso de  la  Inteligencia  Artificial  en  los  sistemas  de  videovigilancia  dentro  del contexto   de   las   ciudades   inteligentes.   Se planteanvarios   conceptos esenciales,  desde  la  Smart  City,  hasta  la  transformación  de  la  seguridad ciudadana  por  medio  de  la  videovigilancia «inteligente».  Se abordan las aplicaciones   actuales tales   elanálisis   predictivo   del   delito   o   el reconocimiento  facialy  los  riesgos  asociados  que  esto  puede  provocar, como  son  la  falta  de  privacidad  y  transparencia.  Mediante  el  estudio  de algunos modelos internacionales de Smart City, se pondrá en evidencia lanecesidad  de  un  marco  normativo  que  garantice  la  protección  de  los derechos fundamentalesy la promoción de un modelo de Smart City que equilibre el desarrollo tecnológico con principios legales y democráticos.
</summary>
<dc:date>2026-05-30T00:00:00Z</dc:date>
</entry>
<entry>
<title>Effects of carob (Ceratonia siliqua) and carob-derived products on glycaemic control and insulin resistance: a systematic review of clinical trials</title>
<link href="http://hdl.handle.net/10952/11022" rel="alternate"/>
<author>
<name>Victoria Montesinos, Desirée</name>
</author>
<author>
<name>González Louzao, Rebeca</name>
</author>
<author>
<name>Barcina Pérez, Pablo</name>
</author>
<author>
<name>Mercader Ros, María Teresa</name>
</author>
<author>
<name>Lucas Abellán, Carmen</name>
</author>
<author>
<name>Daruich González, Iris Beatriz</name>
</author>
<author>
<name>García Muñoz, Ana María</name>
</author>
<id>http://hdl.handle.net/10952/11022</id>
<updated>2026-06-01T10:08:14Z</updated>
<published>2026-06-01T00:00:00Z</published>
<summary type="text">Effects of carob (Ceratonia siliqua) and carob-derived products on glycaemic control and insulin resistance: a systematic review of clinical trials
Victoria Montesinos, Desirée; González Louzao, Rebeca; Barcina Pérez, Pablo; Mercader Ros, María Teresa; Lucas Abellán, Carmen; Daruich González, Iris Beatriz; García Muñoz, Ana María
Carob (Ceratonia siliqua L.) is a traditional Mediterranean ingredient rich in dietary fibre,&#13;
polyphenols, and inositols that is increasingly incorporated into modern foods. However,&#13;
clinical evidence regarding its effects on glycaemic control and insulin resistance remains&#13;
fragmented. This systematic review synthesised evidence from randomised and&#13;
controlled human clinical trials evaluating the effects of carob and carob-derived products&#13;
on postprandial and fasting glycaemic outcomes, as well as insulin resistance markers,&#13;
across different metabolic phenotypes. PubMed, Scopus, the Cochrane Library, and Web&#13;
of Science were searched from inception to the final search date following PRISMA 2020&#13;
guidelines and PROSPERO registration (CRD420251241518). Fifteen clinical trials&#13;
conducted in healthy adults, individuals with prediabetes or insulin resistance, and&#13;
patients with type 2 diabetes were included. In healthy subjects, carob-containing solid&#13;
foods generally elicited low to moderate postprandial glycaemic responses compared with&#13;
conventional carbohydrate controls, whereas isolated carob powder or fibre administered&#13;
in liquid form showed weaker or more variable effects. In metabolically compromised&#13;
populations, carob-pod-derived inositol-enriched preparations and selected carob-based&#13;
functional foods were associated with modest improvements in insulin resistance indices,&#13;
although intervention duration and background dietary changes may influence effect&#13;
magnitude. Evidence in established type 2 diabetes was limited and frequently&#13;
confounded by multi-component interventions. Overall, selected carob-containing foods&#13;
may contribute to lower postprandial glycaemic responses, whereas carob-specific&#13;
insulin-sensitising effects remain preliminary. Longer, adequately powered trials with&#13;
standardised comparators and clinically meaningful endpoints, particularly glycated&#13;
haemoglobin, are required to clarify its role in glycaemic management.
</summary>
<dc:date>2026-06-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>La web 3.0 en el sector hotelero murciano</title>
<link href="http://hdl.handle.net/10952/11021" rel="alternate"/>
<author>
<name>Padilla Piernas, Juana María</name>
</author>
<author>
<name>Parra Meroño, M. Concepción</name>
</author>
<author>
<name>Beltrán Bueno, Miguel Ángel</name>
</author>
<id>http://hdl.handle.net/10952/11021</id>
<updated>2026-05-26T20:00:08Z</updated>
<published>2022-06-06T00:00:00Z</published>
<summary type="text">La web 3.0 en el sector hotelero murciano
Padilla Piernas, Juana María; Parra Meroño, M. Concepción; Beltrán Bueno, Miguel Ángel
Internet ha revolucionado la forma de comunicarnos, siendo la industria turística&#13;
una de las que se encuentran a la cabeza en cuanto a incorporar estos elementos&#13;
a sus webs. El propósito de este trabajo es analizar el grado de integración de las&#13;
herramientas 2.0 y 3.0 en las webs hoteleras, así como su evolución en un periodo&#13;
de 10 años. Se utiliza el método descriptivo para medir el grado de desarrollo de las&#13;
webs y su evolución. Se ha comprobado que los hoteles de la región de Murcia han&#13;
superado la web 2.0 pero aún queda implementar la web 3.0.; The Internet has revolutionised the way we communicate, and the tourism industry&#13;
is one of the leading industries in terms of incorporating these elements into its&#13;
websites. The purpose of this study is to analyse the degree of integration of 2.0 and&#13;
3.0 tools in hotel websites, as well as their evolution over a period of 10 years. The&#13;
descriptive method is used to measure the degree of development of the websites and&#13;
their evolution. It was found that hotels in the region of Murcia have gone beyond&#13;
web 2.0 but still have to implement web 3.0.
</summary>
<dc:date>2022-06-06T00:00:00Z</dc:date>
</entry>
<entry>
<title>Gut microbiota‑modulating interventions in paediatric type 1 diabetes: a systematic review and meta‑analysis</title>
<link href="http://hdl.handle.net/10952/11020" rel="alternate"/>
<author>
<name>Llopis Alonso, Inmaculada</name>
</author>
<author>
<name>Correa Bares, Melania</name>
</author>
<author>
<name>Mercader Ros, María Teresa</name>
</author>
<author>
<name>Lucas Abellán, Carmen</name>
</author>
<author>
<name>García Muñoz, Ana María</name>
</author>
<author>
<name>Victoria Montesinos, Desirée</name>
</author>
<id>http://hdl.handle.net/10952/11020</id>
<updated>2026-05-25T20:00:12Z</updated>
<published>2026-05-25T00:00:00Z</published>
<summary type="text">Gut microbiota‑modulating interventions in paediatric type 1 diabetes: a systematic review and meta‑analysis
Llopis Alonso, Inmaculada; Correa Bares, Melania; Mercader Ros, María Teresa; Lucas Abellán, Carmen; García Muñoz, Ana María; Victoria Montesinos, Desirée
To evaluate the efficacy and safety of gut microbiota-modulating interventions in children and adolescents with type 1&#13;
diabetes. A systematic review and meta-analysis was conducted according to PRISMA 2020. PubMed/MEDLINE, Scopus,&#13;
Web of Science, and CENTRAL were searched from inception to 28 February 2026 for randomised controlled trials of oral&#13;
probiotics, prebiotics, or synbiotics in participants aged ≤ 19 years with type 1 diabetes. Primary outcomes were glycated&#13;
haemoglobin, fasting blood glucose, total daily insulin dose, and C-peptide. Immune-inflammatory, microbiota-related,&#13;
intestinal permeability, and safety outcomes were narratively synthesised. Twelve randomised controlled trials involving&#13;
808 paediatric participants were included. Interventions varied in formulation, dose, and duration. Pooled analyses showed&#13;
significant reductions in glycated haemoglobin and fasting blood glucose, whereas no significant effects were found for total&#13;
daily insulin dose or C-peptide. Immune-inflammatory, microbiota-related, and intestinal permeability outcomes suggested&#13;
possible benefits, but reporting was inconsistent and quantitative pooling was not feasible. Overall, the evidence was limited&#13;
by substantial clinical and methodological heterogeneity.&#13;
Conclusion: Gut microbiota-modulating interventions may improve glycaemic control in children and adolescents with type&#13;
1 diabetes, particularly glycated haemoglobin and fasting blood glucose. However, current evidence is insufficient to support&#13;
any specific formulation, dose, or duration, and larger well-designed paediatric trials are still needed.
</summary>
<dc:date>2026-05-25T00:00:00Z</dc:date>
</entry>
</feed>
